359 related articles for article (PubMed ID: 30352058)
21. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
Evans DS; Alphonsus K; Umaru J; Eigege A; Miri E; Mafuyai H; Gonzales-Peralta C; Adamani W; Pede E; Umbugadu C; Saka Y; Okoeguale B; Richards FO
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3113. PubMed ID: 25233351
[TBL] [Abstract][Full Text] [Related]
22. Situation of onchocerciasis transmission in 2020 in the Cascades region of Burkina Faso.
Guiguemde KT; Sawadogo PM; Zida A; Kima A; Bougma RW; Serme M; Sangaré I; Bougouma C; Bamba S
Parasitol Int; 2024 Feb; 98():102822. PubMed ID: 37940035
[TBL] [Abstract][Full Text] [Related]
23. Onchocerciasis prevalence, human migration and risks for onchocerciasis elimination in the Upper Mouhoun, Nakambé and Nazinon river basins in Burkina Faso.
Nikièma AS; Koala L; Post RJ; Paré AB; Kafando CM; Drabo F; Belem AMG; Dabiré RK; Traoré S
Acta Trop; 2018 Sep; 185():176-182. PubMed ID: 29782820
[TBL] [Abstract][Full Text] [Related]
24. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
25. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
26. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
[TBL] [Abstract][Full Text] [Related]
27. Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone.
Kargbo-Labour I; Bah MS; Melchers NVSV; Conteh A; Redwood-Sawyerr V; Stolk WA; Paye J; Sonnie M; Veinoglou A; Koroma JB; Hodges MH; Weaver AM; Zhang Y
Parasit Vectors; 2024 Mar; 17(1):121. PubMed ID: 38468307
[TBL] [Abstract][Full Text] [Related]
28. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203
[TBL] [Abstract][Full Text] [Related]
29. Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
Efon-Ekangouo A; Nana-Djeunga HC; Nzune-Toche N; Dongmo-Yemele R; Bopda J; Ongbassomben V; Sumo L; Geiger A; Nutman TB; Kamgno J
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011250. PubMed ID: 37058547
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
31. Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone.
Koroma JB; Sesay S; Sonnie M; Hodges MH; Sahr F; Zhang Y; Bockarie MJ
PLoS Negl Trop Dis; 2013; 7(6):e2273. PubMed ID: 23785535
[TBL] [Abstract][Full Text] [Related]
32. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
33. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
[TBL] [Abstract][Full Text] [Related]
34. Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.
Nikièma AS; Koala L; Post RJ; Kima A; Compaoré J; Kafando CM; Nana JB; Bougouma C; Faye B; Traoré S; Dabiré RK
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012118. PubMed ID: 38683750
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
[TBL] [Abstract][Full Text] [Related]
36. Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela.
Vivas-Martínez S; Basáñez MG; Botto C; Villegas L; García M; Curtis CF
Parasitology; 2000 Nov; 121 Pt 5():527-34. PubMed ID: 11128804
[TBL] [Abstract][Full Text] [Related]
37. [Endemic onchocerciasis in forested zones of Ivory Coast: prevalence rate and microfilarial densities].
Diarrassouba S; Traore S; Riviere F
Med Trop (Mars); 1996; 56(1):59-62. PubMed ID: 8767795
[TBL] [Abstract][Full Text] [Related]
38. Reduced prevalence of onchocerciasis following mass treatment with ivermectin.
Oyibo WA; Fagbenro-Beyioku AF
East Afr Med J; 1997 May; 74(5):326-30. PubMed ID: 9337014
[TBL] [Abstract][Full Text] [Related]
39. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.
Bjerum CM; Ouattara AF; Aboulaye M; Kouadio O; Marius VK; Andersen BJ; Weil GJ; Koudou BG; King CL
Clin Infect Dis; 2020 Oct; 71(7):e68-e75. PubMed ID: 31641754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
